7 years of historical data (2018–2024) · Financial Services · Insurance - Brokers
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
GoHealth, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $13M | $134M | $124M | $88M | $402M | $1.2B | — | — |
| Enterprise Value | $500M | $621M | $576M | $629M | $1.0B | $1.4B | — | — |
| P/E Ratio → | -1.53 | — | — | — | — | — | — | — |
| P/S Ratio | 0.02 | 0.17 | 0.17 | 0.14 | 0.38 | 1.31 | — | — |
| P/B Ratio | 0.02 | 0.29 | 0.27 | 0.15 | 0.45 | 0.82 | — | — |
| P/FCF | — | — | 1.30 | 1.86 | — | — | — | — |
| P/OCF | — | — | 1.14 | 1.45 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
GoHealth, Inc.'s enterprise value stands at 5.1x EBITDA, 79% below its 5-year average of 23.9x. The Financial Services sector median is 11.4x, placing the stock at a 56% discount on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.78 | 0.78 | 1.00 | 0.95 | 1.60 | — | — |
| EV / EBITDA | 5.06 | 6.28 | 23.94 | — | — | 41.36 | — | — |
| EV / EBIT | — | 9.15 | — | — | — | — | — | — |
| EV / FCF | — | — | 6.04 | 13.28 | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
GoHealth, Inc. earns an operating margin of -0.9%, below the Financial Services sector average of 21.2%. Operating margins have expanded from -50.4% to -0.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -0.6% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 83.7% | 83.7% | 78.4% | 70.3% | 77.5% | 77.3% | 68.6% | 64.8% |
| Operating Margin | -0.9% | -0.9% | -11.1% | -50.4% | -46.1% | -7.4% | -6.1% | 12.7% |
| Net Profit Margin | -0.4% | -0.4% | -8.6% | -23.5% | -17.8% | -5.0% | -7.6% | 12.4% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | -0.6% | -0.6% | -12.1% | -20.0% | -16.5% | -3.9% | -12.1% | — |
| ROA | -0.2% | -0.2% | -4.0% | -8.0% | -9.1% | -2.4% | -4.7% | 19.7% |
| ROIC | -0.6% | -0.6% | -6.0% | -18.1% | -23.2% | -3.5% | -5.1% | — |
| ROCE | -0.6% | -0.6% | -6.5% | -19.6% | -25.5% | -3.7% | -4.1% | 30.3% |
Solvency and debt-coverage ratios — lower is generally safer
GoHealth, Inc. carries a Debt/EBITDA ratio of 5.3x, which is highly leveraged (29% above the sector average of 4.1x). Net debt stands at $487M ($528M total debt minus $41M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.15 | 1.15 | 1.19 | 0.94 | 0.78 | 0.29 | 0.34 | — |
| Debt / EBITDA | 5.34 | 5.34 | 22.56 | — | — | 11.78 | — | 0.14 |
| Net Debt / Equity | — | 1.06 | 0.99 | 0.91 | 0.69 | 0.18 | 0.32 | — |
| Net Debt / EBITDA | 4.93 | 4.93 | 18.79 | — | — | 7.54 | — | 0.13 |
| Debt / FCF | — | — | 4.74 | 11.41 | — | — | — | — |
| Interest Coverage | -0.10 | -0.10 | -1.18 | -5.58 | -14.61 | -1.96 | -3.99 | 128.41 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.18x means GoHealth, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.56x to 1.18x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | 1.18 | 1.29 | 1.56 | 1.98 | 3.08 | 1.27 | 1.13 |
| Quick Ratio | 1.18 | 1.18 | 1.29 | 1.56 | 1.98 | 3.08 | 1.27 | 1.13 |
| Cash Ratio | 0.12 | 0.12 | 0.25 | 0.06 | 0.39 | 1.13 | 0.11 | 0.01 |
| Asset Turnover | — | 0.54 | 0.49 | 0.38 | 0.51 | 0.42 | 0.34 | 1.58 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
GoHealth, Inc. returns 11.8% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 2.9% | — | — | 0.0% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | 77.0% | 53.7% | — | — | — | — |
| Buyback Yield | 11.8% | 1.1% | 1.9% | 0.4% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 11.8% | 1.1% | 4.7% | 0.4% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $10M | $9M | $8M | $7M | $6M | $21M | $21M |
Compare GOCO with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $13M | -1.5 | 5.1 | — | 83.7% | -0.9% | -0.6% | -0.6% | 5.3 | |
| $212M | 90.2 | 6.7 | — | 38.7% | 4.5% | 10.7% | 5.3% | 4.7 | |
| $62M | -5.9 | 1.5 | — | 97.5% | 12.4% | 5.1% | 6.1% | 1.6 | |
| $10B | 19.0 | 9.5 | 23.8 | 95.7% | 17.7% | 18.5% | 13.9% | 2.0 | |
| $2B | -2.1 | 8.4 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 | |
| $7B | 52.7 | 44.5 | 93.8 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 | |
| $333B | 27.8 | 16.6 | 20.7 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| $30B | 25.0 | 16.8 | 78.9 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 | |
| $111B | 62.5 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| $27B | -4.1 | — | 6.3 | 12.2% | -3.9% | -28.7% | -21.6% | — | |
| $10B | 22.1 | 10.2 | — | 9.0% | 1.7% | 11.0% | 17.4% | 4.0 | |
| Financial Services Median | — | 13.4 | 11.4 | 10.6 | 63.4% | 21.2% | 9.4% | 5.7% | 4.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 7 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs SelectQuote, Inc..
Start ComparisonQuick answers to the most common questions about buying GOCO stock.
GoHealth, Inc.'s current P/E ratio is -1.5x. This places it at the 50th percentile of its historical range.
GoHealth, Inc.'s current EV/EBITDA is 5.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.9x.
GoHealth, Inc.'s return on equity (ROE) is -0.6%. The historical average is -10.9%.
Based on historical data, GoHealth, Inc. is trading at a P/E of -1.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
GoHealth, Inc. has 83.7% gross margin and -0.9% operating margin.
GoHealth, Inc.'s Debt/EBITDA ratio is 5.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.